Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine to reduce flares in ulcerative colitis
IRCT20190713044185N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in autoimmune colitis, sponsored by Tabriz University of Medical Sciences. Primary endpoint: Ulcerative colitis flare frequency. Started Jul 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on IRCT20190713044185N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190713044185N1.